Switch to rituximab shows anti-inflammatory effect in relapsing–remitting MS

Rituximab may be an attractive treatment option for patients with relapsing–remitting multiple sclerosis, suggest phase II study findings showing its efficacy in controlling inflammatory activity.
Source: MedWire News - Category: Consumer Health News Tags: Multiple sclerosis Source Type: news